Molecular Partners Ag (MOLN) Change in Intangibles (2021 - 2024)
Molecular Partners Ag (MOLN) posted quarterly Change in Intangibles of $18447.7 for Q3 2024, down 89.61% year-on-year from $177497.7 in Q4 2023, and up 204.33% on a QoQ basis from -$17682.7 in Q2 2024.
Molecular Partners Ag (MOLN) Change in Intangibles (2021 - 2024) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Change in Intangibles for 4 consecutive years, with $18447.7 the latest figure, recorded in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -66,508.31 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 18,447.69 |
| Sep 30, 2024 | 18,447.69 |
| Jun 30, 2024 | -17,682.74 |
| Jun 30, 2024 | -17,682.74 |
| Mar 31, 2024 | -10.31 |
| Mar 31, 2024 | -10.31 |
| Sep 30, 2023 | 177,497.75 |
| Sep 30, 2023 | 177,497.75 |
| Jun 30, 2023 | -174,505.90 |
| Jun 30, 2023 | -174,505.90 |
| Mar 31, 2023 | -102.71 |
| Mar 31, 2023 | -102.71 |
| Sep 30, 2022 | 113,715.92 |
| Sep 30, 2022 | 113,715.92 |
| Jun 30, 2022 | -114,245.46 |
| Jun 30, 2022 | -114,245.46 |
| Mar 31, 2022 | 34.65 |
| Mar 31, 2022 | 34.65 |
| Sep 30, 2021 | 200,142.72 |
| Sep 30, 2021 | 200,142.72 |